Skip to content

Randomized Controlled Trial of Acupuncture in the Treatment of Diminished ovarian reserve with Insomnia

Randomized Controlled Trial of Acupuncture in the Treatment of Diminished ovarian reserve with Insomnia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001081
Enrollment
Unknown
Registered
2025-05-29
Start date
2025-06-15
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diminished ovarian reserve(DOR)

Interventions

true acupuncture group: true acupuncture
sham acupuncture group:sham acupuncture

Sponsors

Sichuan Jinxin Xinan Women and Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: (1) Age is between 20-45 years old; (2) Meeting the diagnostic criteria for DOR; (3) Regular menstrual cycle (28±7) days; (4) Meeting the diagnostic criteria for chronic insomnia in the International Classification of Sleep Disorders Third Edition (ICSD-3) and having a Pittsburgh Sleep Quality Index (PSQI) score greater than 7 points; (5) Not having used sedative-hypnotic drugs within 1 month before enrollment and not having received acupuncture treatment within the past 3 months; (6) Not participating in other ongoing clinical studies; (7) The patient himself/herself signs the informed consent form or it is signed on behalf of the patient by his/her direct relative. Note: Subjects who meet all the above 7 criteria can be included in this study.

Exclusion criteria

Exclusion criteria: (1) Those with comorbid systemic diseases such as hypertension diabetes mellitus coronary heart disease epilepsy severe cardiovascular and cerebrovascular diseases liver diseases kidney diseases malignant tumors hematopoietic diseases etc.; (2) Those suffering from other types of sleep disorders including sleep apnea syndrome sleep-related movement disorders central sleep disorders narcolepsy restless legs syndrome etc.; (3) Those with alcohol or other drug abuse or dependence; (4) Those with communication and cognitive disorders or suffering from mental diseases such as bipolar disorder anxiety disorder schizophrenia personality change etc.; (5) Patients with a bleeding tendency and those prone to infections or those with severe allergic diseases or those with skin ulcers scars and other conditions that prohibit acupuncture; (6) Those currently participating in other clinical trials. Note: Any patient who meets any of the above criteria will be excluded.

Design outcomes

Primary

MeasureTime frame
Pittsburgh Sleep Quality Index Score;

Secondary

MeasureTime frame
Flinders Fatigue Scale Score;Anti-mullerian hormone;state-trait anxiety inventory Score;the Beck Depression Inventory Score;Epworth Sleepiness Scale Score;Insomnia Severity Index Score;Serum sex hormone levels;Transvaginal B-ultrasonography;morningnsee-evening ness questionnaire Score;Munich chronotype questionnaire Score;

Countries

People's Republic of China

Contacts

Public ContactYang Jie

Chengdu University of Traditional Chinese Medicine

jenny_yang_jie@126.com+86 138 8229 6714

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026